Cancer Immunotherapeutics Members
Behnam Badie, M.D., is a renowned neurosurgeon and expert in the field of surgical neuro-oncology, nanotechnology and T cell research.
Christine Brown, Ph.D., is deputy director of the T Cell Therapeutics Research Laboratory at Beckman Research Institute of City of Hope.
Michael A. Caligiuri, M.D., president of City of Hope National Medical Center, is a world-renowned physician, scientist, builder, innovator, leader and visionary. He is dedicated to developing the next generation of leading-edge cancer therapies.
Don J. Diamond, Ph.D., is Professor in the Department of Hematology & Hematopoietic Cell Transplantation.
Tanya Dorff, M.D., is a medical oncologist and an associate professor in the Department of Medical Oncology & Therapeutics Research.
Mingye Feng, Ph.D., is an associate professor in the Department of Immuno-Oncology
City of Hope's Yuman Fong, M.D., is an internationally recognized expert in cancer of the liver, pancreas, gallbladder and bile ducts. He has led the research effort to employ genetically modified viruses to destroy cancer cells.
Marcin Kortylewski, Ph.D., professor in the Department of Immuno-Oncology, focuses on cancer immunotherapy.
Peter P. Lee, M.D., is professor and chair in the department of Immuno-Oncology, Beckman Research Institute of City of Hope in Southern California and beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer’s Disease and Breast Cancer Research in Honor of Vineta Christopher.
Edwin Manuel, Ph.D., is Assistant Professor in the Department of Immuno-Oncology.
Heather McGee, M.D., Ph.D., is an assistant professor in the Department of Radiation Oncology and Department of Immuno-Oncology at City of Hope.
Laleh G. Melstrom, M.D., M.S., specializes in melanoma and pancreatic cancers.
Joanne Mortimer, M.D., is a breast cancer oncologist and Director of Women's Cancer Programs at City of Hope cancer research hospital.
Javier Gordon Ogembo, Ph.D., is associate professor in the Department of Immuno-Oncology at Beckman Research Institute of City of Hope.
Saul Priceman, Ph.D., is assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation and associate director of Translational Sciences & Technologies in the T Cell Therapeutics Research Laboratories
John Shively, Ph.D., is a professor in the Department of Immunology & Theranostics within the Diabetes & Metabolism Research Institute at City of Hope.
James Waisman, M.D., is one of Southern California's best known and most respected experts on breast cancer.
Leo David Wang, M.D., Ph.D., is a pediatric hematologist oncologist and assistant clinical professor in the departments of Immuno-Oncology and Pediatrics
City of Hope's John Williams, Ph.D., is a Professor in the Department of Cancer Biology and Molecular Medicine and Director of the X-ray Crystallography Core.
Jeffrey Wong, M.D., is renowned for his efforts in targeted therapy using image-guided/intensity modulated radiotherapy, recently applying this approach to bone marrow transplantation.
Yanghee Woo, M.D., is director of the Gastroenterology Minimally Invasive Therapy Program.
Anna Wu, Ph.D., is chair of the Department of Immunology & Theranostics and co-director of the Center for Theranostic Studies.
Paul Yazaki, Ph.D., is a research professor in the Department of Immunology & Theranostics at the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope.
Hua Yu, Ph.D., associate chair of the Department of Immuno-Oncology, has made STAT3 the focus of much of her research.
Jianhua Yu, Ph.D, is Director and Professor, Department of Hematology & Hematopoietic Cell Transplantation, Hematologic Malignancies Research Institute
Chunyan Zhang is a staff scientist in the department of immuno-oncology at the Beckman Research Institute of City of Hope.